ENHANCED GROUP INC. TO BEGIN TRADING ON NYSE

Enhanced Group Inc. has successfully completed its business combination with A Paradise Acquisition Corp., marking a significant milestone as its Class A common stock is set to commence trading on the New York Stock Exchange (NYSE) under the ticker symbol "ENHA." This transition to a public company was officially announced on May 8, 2026, and signifies Enhanced's entry into the capital markets, providing the company with a platform to pursue its growth objectives in the performance medicine sector.

Enhanced Group Inc. focuses on integrating performance enhancements within elite sports, adhering to high clinical standards. The leadership team, led by Co-Founder and CEO Maximilian Martin, is poised to leverage this new public status to revolutionize the performance medicine category. By offering consumers access to cutting-edge health and wellness solutions, Enhanced aims to capitalize on the growing demand for performance optimization. The company's vision aligns with broader trends in health and wellness, where consumers increasingly seek scientifically-backed enhancements to improve their physical capabilities.

The completion of this SPAC transaction comes at a time when the market for performance-enhancing products is evolving, driven by advancements in medical technology and changing consumer attitudes towards health and wellness. Enhanced's strategic positioning in this space is bolstered by its commitment to maintaining the highest ethical standards, which is essential as public scrutiny around performance enhancement continues to grow. The combination with A Paradise Acquisition Corp. not only provides Enhanced with necessary capital but also enhances its visibility and credibility in a competitive landscape.

To commemorate this achievement, Enhanced's leadership team will participate in a ceremonial ringing of the NYSE closing bell, an event scheduled for the same day as the stock listing. This public celebration underscores the company's commitment to transparency and engagement with its stakeholders, including investors and the athletic community. The participation of U.S. Olympic medalists in the ceremony further highlights Enhanced's connection to the sports industry and its dedication to fostering relationships with key figures in athletics.

Looking ahead, the successful listing of Enhanced Group Inc. on the NYSE is expected to have broader implications for the performance medicine sector. As more companies explore similar pathways to public markets through SPAC transactions, Enhanced's entry may serve as a benchmark for future deals in this niche. The evolving landscape of health and wellness, combined with increased consumer interest in performance enhancement, positions Enhanced to potentially lead in this emerging market. The company's ability to navigate regulatory challenges and maintain ethical standards will be critical as it seeks to establish itself as a trusted name in performance medicine.